Response to radiotherapy
Complete response 12(48%)
Partial response 10(40%)
Stable disease 03(12%)
Disease status on last follow up
No evidence of disease 12(48%)
Local recurrence 08(32%)
Metastatic disease 04(16%)
Lost to follow up 04(16%)
Survival
Median follow up 32-months (range 7-76months)
Median Survival 51 months
24months survival 72%
Table 1: Outcome of treatment.